VIRAL SCREENING (HIV,HBS AG,VDRL)

Blood transfusion, a pivotal and frequently utilized therapeutic procedure in contemporary medicine, stands as a cornerstone for saving lives, aligning with the core mission of Hypro Diagnostics. Despite its life-saving potential, concerns persist regarding the transmission of infectious agents during transfusions, leading to what is termed Transfusion Transmitted Infections (TTIs). Viral culprits such as Hepatitis B and C, Human Immunodeficiency Virus (HIV), and the bacterium responsible for syphilis (Treponema pallidum) pose inherent risks of transmission through blood transfusions. To address these concerns, rigorous screening protocols, including the examination of donated blood samples for markers such as Hepatitis B surface antigen (HBsAg), anti-HCV, anti-HIV 1/2, and syphilis antibodies (VDRL: Venereal Disease Research Laboratory), have been established, aligning with the commitment to diagnostic excellence at Hypro Diagnostics. This study, with its focus on analyzing seroprevalence rates among blood donors, aligns with Hypro Diagnostics’ dedication to advancing knowledge and contributing valuable insights that can further enhance the safety and efficacy of blood transfusion practices, ensuring the well-being of both donors and recipients in alignment with Hypro Diagnostics’ unwavering commitment to healthcare excellence.